Calcium supplementation prevents pregnancy-induced hypertension by increasing the production of vascular nitric oxide.
Pregnancy-induced hypertension (PIH) remains a common cause of maternal and fetal morbidity and mortality. During the past 7 years, some progress has been made in the prevention of PIH. Specifically, clinical studies have shown that supplementation with calcium can significantly reduce the frequency of PIH, specially in populations with a low calcium intake. We have suggested that, in such a population, calcium supplementation is a safe and effective measure for reducing the frequency of PIH. Thus, the purpose of this article is to advance a hypothesis about the mechanism by which calcium supplementation reduces the risk of PIH. We propose that dietary calcium supplementation reduces the frequency of PIH by maintaining the serum ionized calcium level which is crucial for the production of endothelial nitric oxide, the increased generation of which maintains the vasodilatation that is characteristic of normal pregnancy.
Mineral Metabolism Unit, Faculty of Medicine, Central University, Quito, Ecuador.
P
P
López-Jaramillo
E
E
Terán
S
S
Moncada
D002118:Calcium / Q000008:administration & dosage / Q000378:metabolism / Q000627:therapeutic use*; D011464:Epoprostenol / Q000096:biosynthesis; D005260:Female; D005313:Fetal Death; D005527:Food, Fortified; D006706:Homeostasis; D006801:Humans; D006973:Hypertension / Q000453:epidemiology / Q000401:mortality / Q000517:prevention & control*; D008955:Models, Cardiovascular; D009017:Morbidity; D009131:Muscle, Smooth, Vascular / Q000378:metabolism / Q000502:physiology / Q000503:physiopathology; D009569:Nitric Oxide / Q000378:metabolism*; D011247:Pregnancy / Q000502:physiology*; D011249:Pregnancy Complications, Cardiovascular / Q000453:epidemiology / Q000401:mortality / Q000517:prevention & control*; D012016:Reference Values; D014664:Vasodilation
D009569:Nitric Oxide; D011464:Epoprostenol; D002118:Calcium